Stocks · News reference
Accuray (NASDAQ:ARAY) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.10) by 80 percent. This is a 300 percent decrease over earnings of $0.01 per share from the same
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Accuray Incorporated (NASDAQ:ARAY), a leading provider of radiation therapy systems for cancer treatment, and RaySearch Laboratories AB (publ) today announced that they had entered into a definitive agreement providing
Accuray (NASDAQ:ARAY) released fourth-quarter financial results and hosted an earnings call on Wednesday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call transcripts and
Fiscal Year 2027 Financial GuidanceAs the Company enters fiscal 2027, management believes Accuray is operating from a position of greater strength than a year ago. The Company expects continued growth in service